| Title: | Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes |
| Journal: | Nature Genetics |
| Published: | 15 Feb 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33589840/ |
| DOI: | https://doi.org/10.1038/s41588-020-00776-w |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610386 |
| Citations: | 322 (178 in last 2 years) as of 8 Aug 2024 |
Publication 9553
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Genome-wide association studies have discovered numerous genomic loci associated with Alzheimer's disease (AD); yet the causal genes and variants are incompletely identified. We performed an updated genome-wide AD meta-analysis, which identified 37 risk loci, including new associations near CCDC6, TSPAN14, NCK2 and SPRED2. Using three SNP-level fine-mapping methods, we identified 21 SNPs with >50% probability each of being causally involved in AD risk and others strongly suggested by functional annotation. We followed this with colocalization analyses across 109 gene expression quantitative trait loci datasets and prioritization of genes by using protein interaction networks and tissue-specific expression. Combining this information into a quantitative score, we found that evidence converged on likely causal genes, including the above four genes, and those at previously discovered AD loci, including BIN1, APH1B, PTK2B, PILRA and CASS4.</p>
13 Authors
- Jeremy Schwartzentruber
- Sarah Cooper
- Jimmy Z. Liu
- Inigo Barrio-Hernandez
- Erica Bello
- Natsuhiko Kumasaka
- Adam M. H. Young
- Robin J. M. Franklin
- Toby Johnson
- Karol Estrada
- Daniel J. Gaffney
- Pedro Beltrao
- Andrew Bassett
Enabling scientific discoveries that improve human health